Christina Barkauskas
Duke Clinical Research Institute · Duke University · Research Director Duke Medical ICU
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christina Barkauskas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:12 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06404086 · RECOVER-SLEEP: Platform ProtocolDuke University · completed · Long COVID, Long COVID-19, Hypersomnia · study chair
- Ph2NCT06404112 · RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)Duke University · completed · Long COVID, Long COVID-19, Sleep Disturbance · study chair
- Ph2NCT06404099 · RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)Duke University · completed · Long COVID, Long COVID-19, Hypersomnia · study chair
- Ph4NCT05822583 · Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy TrialUniversity of Minnesota · completed · COVID-19 · study chair
- N/ANCT05798260 · T-Cell Mitochondrial Respiration Response to Ketone Monoester Supplement in Healthy Volunteers and COVID-19Duke University · withdrawn · COVID-19 Acute Respiratory Distress Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The role of Pdgfra+ fibroblasts in lung fibrosis and alveolar homeostasisK08HL122521 · NHLBI · DUKE UNIVERSITY · fiscal years 2014 to 2018 · $118,590 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:12 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.N Engl J Med · 2021351 citationsRCR 17.1
- A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.Am J Respir Crit Care Med · 202373 citationsRCR 7.5
- Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.Ann Intern Med · 202269 citationsRCR 3.2
- Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial.Ann Intern Med · 202226 citationsRCR 1.4
- Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.Lancet Respir Med · 202318 citationsRCR 1.5
- Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial.Clin Microbiol Infect · 20252 citationsRCR 0.3